News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,437 Results
Type
Article (40999)
Company Profile (267)
Press Release (681161)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204721)
Career Advice (2027)
Deals (35545)
Drug Delivery (111)
Drug Development (81389)
Employer Resources (174)
FDA (16421)
Job Trends (14952)
News (346475)
Policy (32750)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (34)
Adcomms (24)
Allergies (145)
Alliances (49590)
ALS (170)
Alzheimer's disease (1676)
Antibody-drug conjugate (ADC) (314)
Approvals (16692)
Artificial intelligence (520)
Autoimmune disease (160)
Automation (42)
Bankruptcy (361)
Best Places to Work (11638)
BIOSECURE Act (21)
Biosimilars (193)
Biotechnology (174)
Bladder cancer (160)
Brain cancer (57)
Breast cancer (645)
Cancer (4859)
Cardiovascular disease (406)
Career advice (1712)
Career pathing (36)
CAR-T (283)
CDC (46)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (36)
Clinical research (69622)
Collaboration (1718)
Company closure (4)
Compensation (1179)
Complete response letters (57)
COVID-19 (2714)
CRISPR (93)
C-suite (863)
Cystic fibrosis (143)
Data (6304)
Decentralized trials (2)
Denatured (25)
Depression (135)
Diabetes (504)
Diagnostics (6720)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (255)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90265)
Editorial (59)
Employer branding (22)
Employer resources (153)
Events (117425)
Executive appointments (981)
FDA (19573)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1481)
Gene editing (199)
Generative AI (44)
Gene therapy (598)
GLP-1 (968)
Government (4673)
Grass and pollen (6)
Guidances (384)
Healthcare (18884)
HIV (62)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (254)
Immuno-oncology (60)
Indications (119)
Infectious disease (2991)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (254)
Interviews (316)
IPO (16644)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (548)
Leadership (32)
Legal (7957)
Liver cancer (91)
Longevity (15)
Lung cancer (658)
Lymphoma (382)
Machine learning (42)
Management (59)
Manufacturing (809)
MASH (165)
Medical device (13779)
Medtech (13836)
Mergers & acquisitions (19977)
Metabolic disorders (1275)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (321)
Neuropsychiatric disorders (89)
Neuroscience (2924)
Neurotech (1)
NextGen: Class of 2026 (6525)
Non-profit (4515)
Now hiring (68)
Obesity (598)
Opinion (264)
Ovarian cancer (167)
Pain (200)
Pancreatic cancer (230)
Parkinson's disease (284)
Partnered (33)
Patents (507)
Patient recruitment (497)
Peanut (57)
People (58930)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21704)
Phase 2 (30639)
Phase 3 (22829)
Pipeline (5452)
Policy (288)
Postmarket research (2564)
Preclinical (9202)
Press Release (64)
Prostate cancer (240)
Psychedelics (48)
Radiopharmaceuticals (283)
Rare diseases (847)
Real estate (5958)
Recruiting (71)
Regulatory (24566)
Reports (53)
Research institute (2393)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (150)
Series A (240)
Series B (191)
Service/supplier (11)
Sickle cell disease (98)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3619)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1013)
Venture capital (89)
Weight loss (381)
Women's health (93)
Worklife (18)
Date
Today (32)
Last 7 days (575)
Last 30 days (2237)
Last 365 days (29759)
2026 (4014)
2025 (30173)
2024 (35219)
2023 (40090)
2022 (51182)
2021 (55716)
2020 (54096)
2019 (46546)
2018 (35027)
2017 (32142)
2016 (31497)
2015 (37560)
2014 (31322)
2013 (26349)
2012 (28577)
2011 (29266)
2010 (27331)
Location
Africa (737)
Alabama (85)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (39263)
Australia (6417)
California (11401)
Canada (3320)
China (1105)
Colorado (480)
Connecticut (483)
Delaware (341)
Europe (84641)
Florida (1710)
Georgia (361)
Hawaii (3)
Idaho (61)
Illinois (872)
India (70)
Indiana (527)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1394)
Massachusetts (8158)
Michigan (327)
Minnesota (631)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3028)
New Mexico (28)
New York (3004)
North Carolina (1466)
North Dakota (8)
Northern California (5580)
Ohio (338)
Oklahoma (21)
Oregon (41)
Pennsylvania (2306)
Puerto Rico (24)
Rhode Island (48)
South America (1109)
South Carolina (67)
South Dakota (1)
Southern California (4440)
Tennessee (177)
Texas (1755)
United States (40413)
Utah (340)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (928)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,437 Results for "illumina inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Standard BioTools Completes Sale of SomaLogic to Illumina
February 1, 2026
·
6 min read
Press Releases
Illumina and PREMIA partner to expand clinical access to CGP in Asia
January 8, 2026
·
2 min read
Press Releases
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
December 12, 2025
·
4 min read
Press Releases
Greenstone Biosciences and Illumina announce collaboration to advance precision drug discovery
October 24, 2025
·
1 min read
Biotech Beach
Illumina completes the divestiture of GRAIL
Illumina, Inc. announced the successful completion of the spin-off of GRAIL. This milestone follows the company’s previously announced plans to divest GRAIL, and GRAIL is now a public and independent company.
June 24, 2024
·
6 min read
Biotech Beach
Illumina To Webcast Upcoming May 2024 Investor Conference
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 15, 2024
·
1 min read
Biotech Beach
Illumina To Webcast Upcoming Investor Conference - May 03, 2024
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 3, 2024
·
1 min read
Biotech Beach
Illumina releases 2023 Corporate Social Responsibility Report
Illumina Inc., a global leader in DNA sequencing and array-based technologies, published its fifth annual Corporate Social Responsibility Report.
May 28, 2024
·
4 min read
Business
Illumina appoints Everett Cunningham Chief Commercial Officer
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the appointment of Everett Cunningham as Chief Commercial Officer, effective June 10.
June 3, 2024
·
2 min read
Business
Illumina Reports Financial Results for First Quarter of Fiscal Year 2024
Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the first quarter of fiscal year 2024, which include the consolidated financial results for GRAIL.
May 2, 2024
·
24 min read
1 of 72,244
Next
